YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey
| Status: | Completed |
|---|---|
| Conditions: | Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2015 |
| End Date: | November 2015 |
YERVOY Risk Minimisation Tool Evaluation Survey
To evaluate the effectiveness of the YERVOY® educational Risk Minimization (RM) tools in
terms of awareness about these tools, their utilization, knowledge and comprehension of
Immune Related Adverse Reaction (irAR)s, and appropriate behavior by Healthcare Professional
(HCP)s and patients
terms of awareness about these tools, their utilization, knowledge and comprehension of
Immune Related Adverse Reaction (irAR)s, and appropriate behavior by Healthcare Professional
(HCP)s and patients
A total sample size of 160 to 200 HCPs and 160 to 200 patients
For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com
Inclusion Criteria:
- HCP experienced in the treatment of patients with the research compound and patients
that have received at least one dose
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials